FDA — authorised 2 February 1999
- Application: NDA020886
- Marketing authorisation holder: ADVANZ PHARMA
- Local brand name: PANRETIN
- Indication: GEL — TOPICAL
- Status: approved
🇺🇸 Panretin in United States
FDA authorised Panretin on 2 February 1999
Marketing authorisations
FDA
- Status: approved
Panretin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Panretin approved in United States?
Yes. FDA authorised it on 2 February 1999; FDA has authorised it.
Who is the marketing authorisation holder for Panretin in United States?
ADVANZ PHARMA holds the US marketing authorisation.